SCHEMBL25533767

SCHEMBL25533767

CC1(C)c2ccccc2-c2ccc(-c3cc(-c4ccc5ccccc5c4)cc(-c4ccc(-c5cc(-c6ccccc6-c6ccccc6)nc(-c6ccccc6)n5)c5ccccc45)c3)cc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PDK2 Q15119 2/20 0.33
MET P08581 1/20 0.32
ACACA Q13085 1/20 0.32
MAPT P10636 2/20 0.32
NTSR1 P30989 1/20 0.32
HPGD P15428 1/20 0.32
MAOB P27338 2/20 0.31
MAOA P21397 1/20 0.31
CYP17A1 P05093 1/20 0.31
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25534045 0.96 CYP1A1 (0.33) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25538014 0.95 MET (0.37) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25537964 0.95 PDK2 (0.36) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25533746 0.94 CYP1A1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25533762 0.94 CYP1A1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25537915 0.93 CYP1A1 (0.37) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25533744 0.93 PDK2 (0.38) MEN1KMT2AALDH1A1PDK2ACACA
SCHEMBL25534603 0.93 MET (0.33) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25533765 0.93 CYP1A1 (0.39) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25538080 0.92 CYP1A1 (0.36) CYP1A1CYP1B1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM CYP1A1 888/4885CYP1B1 1273/4885MEN1 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.